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Abstract 
Objective:To determine the correlation between initial levels of lactate and 30-day mortality rate in suspicious 
cases of sepsis in pediatrics. 
Methodology:  Study was prospective observational conducted upon 350 patients. The study was held among 
patients of pediatrics department of Nishtar hospital, Multan. Patients of sepsis were included in the study and 
were tested for the hypothesis that there is increased risk of mortality with serum lactate levels more than 
36mg/dL rather than when levels are less than 36mg/dL. For this, different measurements were taken and 
compared at different levels of lactate among the patients with sepsis. SPSS version 24 was used to analyzed 
data and student t-test and chi-square test was applied to see association among variables. P value ≤ 0.05 was 
taken as significant. 
Results: There were 60% (n=105) males and 40% (n=70) females. Comorbidity, oncologic, nononcologic, none 
and central line present was observed as 74.9% (n=131), 27.4% (n=48), 45.1% (n=79), 32.6% (n=57) and 23.4% 
(n=41) respectively. Organ dysfunction, hypotension, hematologic, hepatic and renal was noted as 27.4% 
(n=48), 14.9% (n=26), 17.7% (n=31), 0.6% (n=1) and 16% (n=28) respectively. While, the mean age, heart rate, 
systolic blood pressure, temperature and pulse oximetry of the 3-day hospital mortality patients was 8.11±4.03 
years, 143.21±2.54 bpm, 109.12±3.68 mm Hg, 38.06±1.96 °C and 93.69±2.78 respectively. Conclusion: when 
serum level of lactate is more than 36mg/dL, high risk of mortality is present but with less senistivity. A record 
of initial levels of lactate may prove to be useful in initial risk detection in sepsis in pediatrics. 
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Introduction 
About more 70000 US Children every year are affected by severe pediatric sepsis. mortality rates ranges 
between 5-10% inside the hospital [1]. The failure to recognize the sepsis in children at an early stage has led to 
avoidable mortality [2]. Since the public has shown great concern in the matter of treatable mortality, it has 
compelled the government to formulate laws for the care of pediatric sepsis and has led to the development of 
nationwide quality rectification plans for the prevention of sepsis in neonates by the Children’s Hospital 
Association and American Academy of Pediatrics [3]. A great difficulty in this regard is caused by limited 
diagnostic techniques and trouble in determining the elusive clinical definitions [4]. 
An effective method for the emergency treatment of adults suffering from sepsis is measuring the venous levels 
of lactate and it has proved to be "pay-for-performance metric" [5]. Whereas high levels of lactate is a 
component of adult septic shock definition. there are various factors related to the elevated levels of lactate in 
sepsis; they include anaerobic glycolysis due to decreased tissue perfusion, bioenergetic feedback to sepsis and 
diminished clearance which leads to the increased production of lactate [6,7]. When the venous level of lactate is 
more than 36mg/dL, it increases the risk of mortality in adults, whereas better results have been shown by the 
application of lactate measurements [8]. Determining the levels of lactated has proved to be propitious with 
regards to the prognosis and monitoring the benefits of resuscitation [9]. 
Other than just being a biomarker, the brisk variations in these levels are strongly prognostic during initial 
treatment of pediatric sepsis. There is reserved documentation regarding the applicability of determination of 
initial levels of lactate, thence its utility in the guidelines for pediatric sepsis is not approved. This study has been 
carried out to establish if the early venous levels of lactate in crises of pediatric sepsis is related to the mortality 
within 30 days interval [10]. An early level of serum lactate more than 36mg/dL is hypothesized in the study to 
be affiliated with higher mortality rates rather than the concentration at 36mg/dL or less. As a subsidiary 
investigation, determination of clinical results in the patients organized by levels of lactate was done. 
 
Methodology 
The study design was a prospective observational of clinical sepsis formulated to guide the quality of 
amendment work. It was approved by the related authorities.the study was carried out at emergency department 
of Nishtar hospital, Multan. The emergency department code consisted of incitement procedure for suspicious 
cases of sepsis. It included a protocolized assortment of instruments and added members and arranged a set of 
standard processes to be used rapidly for the induction of IV access, antibiotic administration, fluid resuscitation, 
along with clinical therapeutics. Testing for lactate is recommended however clinicians have the authority to 
override the given sequence upon their own judgment. 
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Study included all the patients registered in the sepsis recognition and treatment registry in the period of initial 
45 months of surgery. The exclusion criteria included those patients less than 60 days old or greater than 18 
years, transfer of patient separate medical care facility, or those patients whose serum levels of lactate were not 
measured during initial 8 hours of arrival in ED. Inclusion criteria was based on the assessment of levels of 
venous lactate. the fundamental end result was mortality rates due to all causes within the hospital stay after 30 
days of arrival in ED. The supplementary outcomes comprised of hospital stay more than 3 days, administration 
of vasoactive agents, ICU stay more than 2 days, days spent on the ventilator, days treated with vasoactive 
agents. 
The primal exposure was an early level of venous lactate more than 36mg/dL. patients having their venous 
lactate levels calculated within the initial 48 hours were given due consideration. the initially measured levels of 
lactate were considered only. The levels were determined on the basis of adult data having lactate levels more 
than 36mg/dL considered a risk factor for mortality. As a supplementary evaluation, levels of lactate were 
termed as high >36mg/dL, intermediate 18-36mg/dL, and low <18mg/dL and expressed as apt variables. 
Approved instruments were used to measure the levels of lactate. Medical literature was utilized to determine the 
covariates, containing variables belonging to risk scoring in pediatric infectious and adult sepsis. In order to 
determine the aspect of bowel ischemia, operative cases and death were analyzed again to establish if an 
abdominal origin of sepsis was present, and this abdominal root was taken as the covariate in the analysis of 
multivariable. In the case of missing lab investigations and values, to determine the organ dysfunction, levels 
were attributed not beyond the clinical confines as a customary clinical practice. SAS software was used to 
analyze the data. For the statistics of continuous variables and percentage and frequency of categorical variables, 
recognized definitive figures were recorded within median range. SPSS version 24 was used to analyzed, mean 
and SD was calculated for numerical variables like age, systolic blood pressure, heart rate, temperature and pulse 
oximetery. Qualitative data was analyzed for frequency and percentages like gender and comorbidities. Student 
t-test and chi-square test was applied to see association among variables. P value ≤ 0.05 was taken as significant. 
 
Results 
A total number of 100% (n=350) patients were enrolled in this study, both genders. This study was further 
divided into two equal groups i.e. 50% (n=175) in each. The mean age, heart rate, systolic blood pressure, 
temperature and pulse oximetry of the patients lactate level ≤36 mg/dL was 7.28±4.31 years, 142.07±4.09 bpm, 
108.20±3.76 mm Hg, 38.99±2.09 °C and 96.08±2.64 respectively. There were 64.6% (n=113) males and 35.4% 
(n=62) females. Comorbidity, oncologic, Nononcologic, none and central line present was observed as 77.1% 
(n=135), 36.6% (n=64), 41.7% (n=73), 34.3% (n=60) and 24.6% (n=43) respectively. ED organ dysfunctiona, 
cardiovascular, hematologic, hepatic and renal was noted as 29.1% (n=51), 24% (n=42), 12.6% (n=22), 9.7% 
(n=17) and 4.6% (n=8) respectively. While, the mean age, heart rate, systolic blood pressure, temperature and 
pulse oximetry of the patients lactate level >36 mg/dL was 9.16±5.37 years, 156.04±4.79 bpm, 109.22±4.82 mm 
Hg, 39.35±2.63 °C and 95.85±2.86  respectively. There were 58.3% (n=102) males and 41.7% (n=73) females. 
Comorbidity, oncologic, nononcologic, none and central line present was observed as 72% (n=126), 14.3% 
(n=25), 14.9% (n=26), 54.9% (n=96) and 29.1% (n=51) respectively. ED organ dysfunctiona, cardiovascular, 
hematologic, hepatic and renal was noted as 26.9% (n=47), 25.1% (n=44), 10.3% (n=18), 15.4% (n=27) and 
5.1% (n=9) respectively. The differences were statistically significant of age (p=0.000), heart rate (p=0.000), 
oncologic (p=0.000), nononcologic (p=0.000) and none (p=0.000). (Table. 1). 
The mean age, heart rate, systolic blood pressure, temperature and pulse oximetry of the survived patient was 
5.73±4.41 years, 142.62±2.54 bpm, 109.12±3.68 mm Hg, 38.06±1.95 °C and 96.01±1.98 respectively. There 
were 60% (n=105) males and 40% (n=70) females. Comorbidity, oncologic, nononcologic, none and central line 
present was observed as 74.9% (n=131), 27.4% (n=48), 45.1% (n=79), 32.6% (n=57) and 23.4% (n=41) 
respectively. Organ dysfunctiona, hypotension, hematologic, hepatic and renal was noted as 27.4% (n=48), 
14.9% (n=26), 17.7% (n=31), 0.6% (n=1) and 16% (n=28) respectively. While, the mean age, heart rate, systolic 
blood pressure, temperature and pulse oximetry of the 3-day hospital mortality patients was 8.11±4.03 years, 
143.21±2.54 bpm, 109.12±3.68 mm Hg, 38.06±1.96 °C and 93.69±2.78 respectively. There were 66.9% (n=117) 
males and 33.1% (n=58) females. Comorbidity, oncologic, Nononcologic, none and central line present was 
observed as 94.9% (n=166), 54.3% (n=95), 45.7% (n=80), 2.3% (n=4) and 23.4% (n=41) respectively. Organ 
dysfunctiona, hypotension, hematologic, hepatic and renal was noted as 46.3% (n=81), 32% (n=56), 39.4% 
(n=69), 1.1% (n=2) and 9.1% (n=16) respectively. The differences were statistically significant of age (p=0.000), 
systolic blood pressure (p=0.000), temperature (p=0.001), pulse oximetry (p=0.000), comorbidity (p=0.000), 
oncologic (p=0.000), none (p=0.000), organ dysfunctiona (p=0.000), hypotension (p=0.000) and hematologic 
(p=0.000). 
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Table. 1   Study Population Demographics and Initial Clinical  Characteristics by Lactate Level 
Characteristics Lactate Level ≤36 
mg/dL (n=175) 
Lactate Level >36 mg/dL 
(n=175) 
P Value 
Gender 
Male 64.6% (n=113) 58.3% (n=102) 0.227 
Female 35.4% (n=62) 41.7% (n=73) 
Age (years) 7.28±4.31 9.16±5.37 0.000 
Heart rate, bpm 142.07±4.09 156.04±4.79 0.000 
Systolic blood 
pressure, mm Hg 
108.20±3.76 109.22±4.82 0.028 
Temperature, °C 38.99±2.09 39.35±2.63 0.158 
Pulse oximetry 96.08±2.64 95.85±2.86 0.439 
Comorbidity 77.1% (n=135) 72% (n=126) 0.269 
Oncologic 36.6% (n=64) 14.3% (n=25) 0.000 
Nononcologic 41.7% (n=73) 14.9% (n=26) 0.000 
None 34.3% (n=60) 54.9% (n=96) 0.000 
Central line 
present 
24.6% (n=43) 29.1% (n=51) χ2=0.93,p=0.335 
ED organ 
dysfunctiona 
29.1% (n=51) 26.9% (n=47) 0.634 
Cardiovascular 24% (n=42) 25.1% (n=44) 0.804 
Hematologic 12.6% (n=22) 10.3% (n=18) 0.502 
Hepatic 9.7% (n=17) 15.4% (n=27) 0.107 
Renal 4.6% (n=8) 5.1% (n=9) 0.804 
 
Table. 2   Study Population Demographics and Initial Clinical  Characteristics by Mortality Status 
Characteristics Survived 3-day hospital mortality P Value 
Gender 
Male 60% (n=105) 66.9% (n=117) 0.183 
Female 40% (n=70) 33.1% (n=58) 
Age (years) 5.73±4.41 8.11±4.03 0.000 
Heart rate, bpm 142.62±2.54 143.21±2.54 0.048 
Systolic blood 
pressure, mm Hg 
109.12±3.68 109.12±3.68 0.000 
Temperature, °C 38.06±1.95 38.06±1.96 0.001 
Pulse oximetry 96.01±1.98 93.69±2.78 0.000 
Comorbidity 74.9% (n=131) 94.9% (n=166) 0.000 
Oncologic 27.4% (n=48) 54.3% (n=95) 0.000 
Nononcologic 45.1% (n=79) 45.7% (n=80) 0.915 
None 32.6% (n=57) 2.3% (n=4) 0.000 
Central line 
present 
23.4% (n=41) 23.4% (n=41) 1.0 
Organ 
dysfunctiona 
27.4% (n=48) 46.3% (n=81) 0.000 
Hypotension 14.9% (n=26) 32% (n=56) 0.000 
Hematologic 17.7% (n=31) 39.4% (n=69) 0.000 
Hepatic 0.6% (n=1) 1.1% (n=2) 0.562 
Renal 16% (n=28) 9.1% (n=16) 0.053 
 
Discussion 
Increased levels of lactate are a typical presentation of shock when consumption of oxygen becomes entirely 
dependant on the delivery of oxygen. In such cases,  levels prove to be efficient biological markers and 
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prognostic tool. As stated by Okorie N et al [11] the levels of lactate represent a measurement of "inadequate 
perfusion and tissue hypoxia". It has been supported by observation as well as clinical experimentation. it is 
observed that increased levels of lactate can be regarded as "screening tool" and they assist in the identification 
of patients having underlying hypoperfusion of tissues before the onset of symptoms. 
The normal levels of lactate in the serum are found to be 2mmol/L. hence, Varis E et al [12], found that patients 
with plasma levels >2mmol/L at the time of admission, suffered high "90-day mortality". While patients having 
persistently elevated lactate levels, at 72 hours had an even greater 90-day mortality rate. It was observed that 
time-weighted mean value of lactate at the point of 72 hours and the elevated lactate levels were associated with 
90-day mortality independently. Further clinical research is encouraged in this regard to determine the mortality 
rate in patients with septic shock. 
A study performed by --anony [13]showed that there is a correlation between increased levels of lactate/albumin 
and the progression of MODS as well as mortality in the patients suffering from septic shock and severe sepsis. 
Lactate/albumin levels were said to be "independent predictor" of MODS in the period of ICU stay. They were 
predicted to be directly proportional to the "Acute Physiology and Chronic Health Evaluation II score". It shows 
that if the lactate levels are predetermined, they prove to be useful in predicting the mortality rates in the cases of 
severe sepsis. 
A similar study carried out by Adam J. et al [14] included the patients of same age and gender as well as same 
levels of lactate and severity of sepsis and SOFA score. At the end of the study, upon administration of POC 
lactate, it was found that there was remarkable decline the mortality rate and the ICU admissions. It was 
concluded that introduction of POC lactate levels calculation in emergency department among patients with 
severe sepsis, not only buys time to test the results and administer IV fluids but also brings about a significant 
decrease in the rate of mortality and admissions in ICU. 
A study conducted by Chertoff J et al [15], demonstrated that in septic patients, the lower levels of plasma 
clearance were associated with high rates of 30-days mortality and it requires the administration of vasopressors 
in such patients. The authors refer these levels as useful measurements for directing the treatment in late sepsis. 
Furthermore, research is advised to determine the underlying process and targets for better clearance of lactate 
levels in late sepsis to decrease the mortality rates and increase the possibility of better outcomes. 
A retrospective cohort study by Filho R et al [16] was showed that increased risk of mortality was associated 
with early levels of lactate greater than 2.5mmol/L in patients with septic shock or severe sepsis in the 
emergency department. It should be focused on the importance of decreased levels of lactate as in initiative clue 
for resuscitation in the severely ill patients for the prevention of morbidity and mortality. Similarly, it was 
observed by Scott H et al [17], the risk of persisting organ dysfunction decreases with lactate rehabilitation 
within four hours. The study found out that the relationship between normalization of lactate levels and declining 
risk of organ dysfunction remains in the groups having initial levels of lactate less than 2mmol/L along with 
hypotension. The study suggested that a series of measurements of lactate levels in such patients may prove to be 
a "useful prognostic tool" in the resuscitation during the first few hours of sepsis in pediatrics. 
In a systemic review done by Puskarich M [18] it was seen that for the patients admitted in the emergency 
department, with suspicion of infection, intermediate levels of lactate were correlated with "moderate to high-
risk mortality". The authors describe that out of 11062 patients having intermediate levels of lactate during their 
infection, 1672 patients expired. It was advised for the physicians to closely monitor such patients along with 
vigorous treatment strategies. 
The levels of serum venous lactate are a "promising risk stratification tool" as claimed by Shairo N et al [19]. 
they found that rate of mortality increases with increase in serum lactate levels. It was based on the observation 
that out 4.9% of deaths occurred in patients having mildly elevated serum lactate levels, while for moderately 
elevated levels of lactate, the mortality rate was 9%, similarly patients having severely elevated lactate levels 
experienced 28.4% mortality. The sensitivity of lactate levels for any death was calculated to be 36 while 
specificity was found to be 92%. It is suggested that before starting the clinical maneuvers, the comparison of 
lactate levels must be made. 
Another study [20] determines the correlation between early lactate levels and rate of mortality between sepsis in 
pediatric presented to the emergency department. The study emphasizes the usefulness of testing lactate levels in 
the emergency rehabilitation of sepsis management in pediatrics. Furthermore, the study confirms the previous 
researches upon the relationship of initial levels of lactate and organ dysfunction as well as the mortality rates. 
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Further research is appreciated to determine the better outcome in the management of sepsis by the measurement 
of lactate levels. 
Conclusion 
When serum level of lactate is more than 36mg/dL, high risk of mortality is present but with less senistivity. A 
record of initial levels of lactate may prove to be useful in initial risk detection in sepsis in pediatrics. Further 
research must be carried out to determine the usefulness of measurment of initial lactate levels in order to have 
better outcome in pediatric sepsis. 
References 
1. McClead R, Balamuth F, Brady P, Weiss SL, Elizebeth R, Neuman MI, et al. Pediatric 
severe sepsis in U.S. children’s hospitals. Pediatr Crit Care Med. 2014;15(9):798-805. 
 
2. Singer M, Annand D, Deutschman CS, Bauer M, Seymour CW, Gordon R et al. 
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-
810. 
 
3.  Jones AE, Puskarich MA, , MasseyMJ, Shapiro NI, Kline JA. Lactate clearance in septic shock is not a 
surrogate for improved microcirculatory flow. Acad Emerg Med. 2016;23(6):690-693 
 
4.  Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Crit Care. 2014; 18(5):503 
 
5. Casserly B, Tiffany M, Phillips GS, Mitchell M,  Schorr C, Sean R, et al. Lactate 
measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis 
Campaign database. Crit Care Med. 2015;43(3):567-573. 
 
6. Seymour CW, Christopher W, Liu VX, Vincent X, Iwashyna TJ, Theodore J, et al. 
Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic 
Shock (Sepsis-3). JAMA. 2016;315(8):762-774. 
 
7. Melendez E, Paul R, Stack A, Capraro A,Neuman MI, Monuteaux M, . Improving adherence to PALS septic 
shock guidelines. Pediatrics. 2014;133(5):e1358-e1366. 
 
8. Thompson GC, Macias CG. Recognition and management of sepsis in children: practice patterns in the 
emergency department. J Emerg Med. 2015;49(4):391-399. 
 
9. Jhamb U, Jat KR, Gupta VK. Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian 
J Crit Care Med. 2011;15(2):102-107. 
 
10. Duke TD, ButtW, South M. Predictors of mortality and multiple organ failure in children with sepsis. 
Intensive Care Med. 1997;23(6):684-692. 
 
11. Okorie N, Dellinger P. Lactate: Biomarker and Potential Therapeutic Target. Crit Care Clin 27.  2011; 299–
326. 
 
12. Varis E, Pettila V, Poukkanen M, Stephan M, Karlsson S, Perner A et al. 2017EVOLUTION OF BLOOD 
LACTATE AND 90-DAY MORTALITY IN SEPTIC SHOCK. A POST HOC ANALYSIS OF THE FINNAKI 
STUDY. SHOCK. 2017;47( 5)574–581. 
 
13. Wang B, Chen G, Cao Y, Xue J, Li J, Wu Y. Correlation of lactate/albumin ratio level to organ failure and 
mortality in severe sepsis and septic shock====Absolute lactate value vs relative reduction as a predictor of 
mortality in severe sepsis and septic shock. Journal of Critical Care. April 2015;37(2):271-275 
14. Adam J., Taylor M, LeBlanc D, Williams J, Henry C, Thode J. ED bedside point-of-care lactate in patients 
with suspected sepsis is associated with reduced time to iv fluids and mortality. Am J Emerg Med. Sept 
2014;32(9):1120-1124 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.45, 2018 
 
83 
 
15. Chertoff J, Chisum M, Simmons L, King B, Walker M, Lascano J. Prognostic utility of plasma lactate 
measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe 
sepsis, and septic shock. Journal of Intensive Care. 2016;4(13):00-00 
16. Filho R, Rocha L, Correa T, Pessoa C, Colombo G, Assuncao M. Blood Lactate Levels Cutoff and Mortality 
Prediction in Sepsis—Time for a Reappraisal? a Retrospective Cohort Study. Shock. 2016;46(5):480–485. 
17. Scott H, Brou L, Deakyne S, Fairclough D, Kempe A, Bajaj L. Lactate Clearance and Normalization and 
Prolonged Organ Dysfunction in Pediatric Sepsis. The Journal of Pediatrics. 2016;170:149-155. 
18. Puskarich M, Illich B, Jones A. Prognosis of emergency department patients with suspected infection and 
intermediate lactate levels: A systematic review.  2014;29(3):334–339 
19. Shapiro N, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW et al. Serum lactate as a predictor of 
mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524-8. 
20. Scott H, Bajaj L, Daekyne S, Fairclough D, Brou L, Kempe A. Association Between Early Lactate Levels 
and 30-Day Mortality in Clinically Suspected Sepsis in Children. Jama Pediatrics. 2017;171(3):249–255. 
 
